Consensus report IASLC workshop Bruges, September 2002: Pretreatment minimal staging for non-small cell lung cancer

Lung Cancer

Volumn 42, Issue 2 SUPPL., 2003, Pages

  Postmus, Pieter E ^a   Rocmans, Pierre ^b   Asamura, Hisao ^c   Ball, David ^d   Belderbos, José ^e   Cappello, Matteo ^b   Jassem, Jacek ^f   Novello, Silvia ^g   Pass, Harvey ^h   Passlick, Bernward ⁱ   Pirker, Robert ^j   Ready, Neal ^k   Sause, William ^l   Scagliotti, Giorgio ^g   Vansteenkiste, Johan ^m   Westeel, Virginie ⁿ   Van Zandwijk, Nico ^e  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ERASME HOSPITAL   (Belgium)

^c NATIONAL CANCER CENTER HOSPITAL   (Japan)

^d PETER MACCALLUM CANCER CENTRE   (Australia)

^e NETHERLANDS CANCER INSTITUTE   (Netherlands)

^f MEDICAL UNIVERSITY OF GDANSK   (Poland)

^g UNIVERSITY OF TURIN   (Italy)

^h WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁱ UNIVERSITY OF MUNICH   (Germany)

^j UNIVERSITY OF VIENNA   (Austria)

^k BROWN UNIVERSITY   (United States)

^l LDS HOSPITAL   (United States)

^m UNIVERSITY OF LEUVEN   (Belgium)

ⁿ UNIVERSITY HOSPITAL OF BESANÇON   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADJUVANT THERAPY; BONE SCINTISCANNING; BRONCHOSCOPY; CANCER STAGING; CANCER THERAPY; CLINICAL PROTOCOL; CONFERENCE PAPER; HUMAN; LUNG NON SMALL CELL CANCER; MEDICAL SOCIETY; NUCLEAR MAGNETIC RESONANCE IMAGING; PREOPERATIVE PERIOD; PRIORITY JOURNAL; TREATMENT PLANNING; WORKSHOP;

EID: 10744224483     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-5002(03)00296-4     Document Type: Conference Paper

References (12)

1. Tonato M. Final report of the adjuvant lung project Italy (ALPI): an Italian/EORTC-LCG randomised trial of adjuvant chemotherapy in completely resected non-small cell lung cancer (NSCLC). Proc. Am. Soc. Clin. Oncol. 21:2002;290a. abstract 1157.
2. Depierre A., Milleron B., Moro-Sibilol D., et al. Preoperative chemotherapy followed by surgery compared with primary surgery in resectable stage I (except T1N0), II and IIIa non-small cell lung cancer. J. Clin. Oncol. 20:2002;247-253.
3. Cullen M.H., Billingbam L.J., Woodrofe C.M., et al. Mitomycin, ifosfamide, and cisplatin in unrespectable non-small-cell lung cancer: effects on survival and quality of life. J. Clin. Oncol. 17:1999;3188-3194.
4. Archer V.R., Billingham L.J., Cullen M.H. Palliative chemotherapy: no longer a contradiction in terms. Oncologist. 4:1999;470-477.
5. Wiersema M.J., Wazquez-Scqueiros E., Wiersema L. Evaluation of mediastinal lymph-adenopathy with endoscopic US-guided fine-needle aspiration biopsy. Radiology. 219:2001;252-257.
6. Pieterman R.M., van Putten J.W., Meuzelaar J.J., et al. Preoperative staging of non-small-cell lung cancer with positron-emission tomography. New Engl. J. Med. 343:2000;254-261.
7. Sutedja T.G., Codrington H., Risse E.K., et al. Autofluorescence bronchoscopy improves staging of radiographically occult lung cancer and has an impact on therapeutic strategy. Chest. 120:2001;1327-1332.
8. Schoenfeld N., Loddenkemper R. Pleural biopsy and thoracoscopy. Eur. Respir. Mon. 9:1998;135-152.
9. Feld R., Abratt R., Graziano S., et al. Pretreatment minimal staging and prognostic factors for non-small cell lung cancer. Lung Cancer. 17:(Suppl.):1997;S3-S10.
10. Mountain C.F. Revisions in the international system for staging lung cancer. Chest. 111:1997;1710-1717.
11. van Tinteren H., Hoekstra O.S., Smil E.F., et al. Effectiveness of positron emission tomography in the preoperative assessment of patients with suspected non-small-cell lung cancer: the PLUS multicentre randomised trial. Lancet. 359:2002;1388-1393.
12. Mac Manus M.P., Wong K., Hicks R.J., et al. Early mortality after radical radiotherapy for non-small-cell lung cancer: comparison of PET-staged and conventionally staged cohorts treated at a large tertiary referral center. Int. J. Radiat. Oncol. Biol. Phys. 52:2002;351-361.